Teacher Retirement System of Texas Trims Stock Holdings in Phibro Animal Health Corporation (NASDAQ:PAHC)

Teacher Retirement System of Texas lessened its stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 75.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,246 shares of the company's stock after selling 57,605 shares during the period. Teacher Retirement System of Texas' holdings in Phibro Animal Health were worth $411,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Sterling Capital Management LLC raised its stake in shares of Phibro Animal Health by 2.4% during the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock worth $394,000 after buying an additional 448 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Phibro Animal Health during the 4th quarter worth approximately $29,000. Price T Rowe Associates Inc. MD raised its stake in shares of Phibro Animal Health by 9.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,668 shares of the company's stock worth $372,000 after buying an additional 1,565 shares during the period. Lazard Asset Management LLC raised its stake in shares of Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after buying an additional 1,589 shares during the period. Finally, Quantbot Technologies LP raised its stake in shares of Phibro Animal Health by 65.1% during the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after buying an additional 2,018 shares during the period. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Trading Down 1.1%

Shares of PAHC traded down $0.32 during midday trading on Friday, reaching $29.41. The company had a trading volume of 353,025 shares, compared to its average volume of 224,061. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $31.80. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The firm has a 50 day simple moving average of $25.63 and a 200-day simple moving average of $22.70. The stock has a market cap of $1.19 billion, a PE ratio of 37.71, a price-to-earnings-growth ratio of 0.51 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The business had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Research analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th were issued a dividend of $0.12 per share. The ex-dividend date was Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.63%. Phibro Animal Health's dividend payout ratio is presently 61.54%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PAHC. BNP Paribas raised Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $25.00 to $35.00 in a report on Monday, July 7th. Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the company an "equal weight" rating in a report on Wednesday, June 25th. Finally, BNP Paribas Exane upgraded Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a report on Monday, June 16th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, Phibro Animal Health presently has an average rating of "Hold" and a consensus price target of $24.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.